261 – 270 of 410
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2006
-
Mark
Intact Free Prostate-Specific Antigen and Free and Total Human Glandular Kallikrein 2. Elimination of Assay Interference by Enzymatic Digestion of Antibodies to F(ab')(2) Fragments.
(
- Contribution to journal › Article
-
Mark
High-speed biomarker identification utilizing porous silicon nanovial arrays and MALDI-TOF mass spectrometry
(
- Contribution to journal › Article
-
Mark
Immunohistochemical detection of cysteine-rich secretory protein 3 in tissue and in serum from men with cancer or benign enlargement of the prostate gland.
(
- Contribution to journal › Article
-
Mark
Reproducibility and Accuracy of Measurements of Free and Total Prostate-Specific Antigen in Serum vs Plasma after Long-Term Storage at -20 {degrees}C.
(
- Contribution to journal › Article
-
Mark
Enhanced discrimination of benign from malignant prostatic disease by selective measurements of cleaved forms of urokinase receptor in serum
(
- Contribution to journal › Article
-
Mark
Defining biochemical recurrence of prostate cancer after radical prostatectomy: a proposal for a standardized definition
(
- Contribution to journal › Article
-
Mark
Pharmacokinetics, biodistribution, and antitumor efficacy of a human glandular kallikrein 2 (hK2)-activated thapsigargin prodrug
(
- Contribution to journal › Article
-
Mark
Risk assessment for biochemical recurrence prior to radical prostatectomy: significant enhancement contributed by human glandular kallikrein 2 (hk2) and free prostate specific antigen (PSA) in men with moderate PSA-elevation in serum
(
- Contribution to journal › Article
-
Mark
Differential exoprotease activities confer tumor-specific serum peptidome patterns
(
- Contribution to journal › Article
-
Mark
A comprehensive nomenclature for serine proteases with homology to tissue kallikreins.
(
- Contribution to journal › Article